Hervolution Therapeutics
InProTher develops BreakImmune, a cancer immunotherapy that targets HERVs (expressed in breast, prostate, ovarian, and pancreatic malignancies). HERVs help the immune system eliminate tumor cells. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD41—61m (Dealroom.co estimates May 2023.)
Company register number 33968426
Copenhagen Capital Region of Denmark (HQ)
Authorizing premium user...